Skip to main content
The Lotus Endometriosis Institute Logo
A beautiful landscape of lotus flowers

Adenomyosis and Fertility: What Patients Need to Know

How can adenomyosis affect conception, IVF, and pregnancy?

Flat vector illustration of a symbolic tree with roots and branches forming a womb silhouette and eggs among the roots, representing hope and fertility in adenomyosis.

Adenomyosis is often explained to patients as a “thickened” or “bulky” uterus that can cause heavy bleeding and painful periods. What many people don’t hear at presumptive diagnosis is a clear answer to the next question: Will this affect my ability to get pregnant or stay pregnant?


Fertility outcomes with adenomyosis vary widely. Party this is because adenomyosis isn’t one single pattern of disease. Some people have focal adenomyosis (more localized), others have diffuse disease (spread throughout the muscle), and many have changes in the junctional zone (JZ), the inner layer of uterine muscle that seems especially important for implantation and early pregnancy. Across multiple recent studies, the overall message is consistent: adenomyosis can make conception and pregnancy harder for some patients, but risk depends on disease features, age/ovarian reserve, and treatment strategy.


How can adenomyosis affect fertility?


1) Implantation may be less reliable (even with good embryos)


Several lines of evidence suggest adenomyosis can interfere with the uterus becoming “receptive” during the implantation window.


A recent single-cell study examining the uterine lining (endometrium) during the mid‑secretory phase—when implantation normally occurs—found patterns consistent with a lining that stays in a more growth/proliferation mode and shows signs of impaired maturation/differentiation. The researchers also reported impaired stromal “decidualization,” a key transformation the lining undergoes to support early pregnancy. This kind of mechanistic research doesn’t tell you what to do tomorrow, but it supports a plausible biological explanation for why some people with adenomyosis struggle with implantation.


2) IVF outcomes are often lower in observational studies


When researchers compare IVF outcomes in people with and without adenomyosis, many observational studies find lower clinical pregnancy and live birth rates and higher miscarriage rates in the adenomyosis groups. A recent review reported pooled results from comparative observational studies showing reduced odds of clinical pregnancy and live birth and increased odds of miscarriage in adenomyosis compared with no adenomyosis.


Importantly, adenomyosis may not affect everyone the same way. Reviews consistently emphasize worse outcomes particularly in diffuse disease and when the junctional zone is involved—details that are often available in ultrasound or MRI reports but usually not well explained to patients.


3) Your “uterus factors” are only part of the picture


One reason adenomyosis sub-fertility factors can feel confusing is that the uterus matters, a lot—but so do ovarian reserve and embryo/lab factors.


A 2026 prediction-modeling study using ultrasound features (based on MUSA criteria) plus clinical variables found only modest ability to predict cumulative live birth after IVF/ICSI from pre-treatment information alone. The strongest predictor was AMH (a marker of ovarian reserve), and among ultrasound features, a regular junctional zone carried more predictive weight than many classic “direct” adenomyosis signs. When the model added IVF-cycle details (like embryo stage and transfer type), prediction improved and embryo-stage variables dominated—underscoring a practical point: adenomyosis matters, but it’s rarely the only driver of IVF success.


If you’re trying to conceive: what are realistic expectations?


For spontaneous conception, high-quality comparative data are limited, and many studies include mixed groups (different ages, different infertility diagnoses, different adenomyosis subtypes). For IVF/ART, the evidence base is larger but still mostly observational and not based on any kind of clinical trials.


What you can take from the combined evidence is this: if you have adenomyosis, it is reasonable to plan for (1) a more individualized approach and (2) possibly needing more time or more than one strategy—especially if imaging suggests diffuse disease or junctional zone disruption.


IVF with adenomyosis: what treatment strategies are supported?


Fertility clinics commonly try to improve outcomes by changing when embryos are transferred and how the uterus is prepared.


Freeze-all and frozen embryo transfer (FET) often makes sense


Across recent reviews, one of the most consistent themes is that many patients with adenomyosis may do better with a freeze-all strategy (create embryos first, freeze them, then transfer later) rather than transferring fresh embryos in the same stimulation cycle.


Why might this help? Ovarian stimulation raises estrogen levels, and adenomyosis is considered estrogen-responsive. The idea behind freezing is to avoid transferring into an inflamed or hormonally “too stimulated” uterine environment and instead transfer in a more controlled cycle.


Multiple retrospective datasets summarized in narrative reviews suggest improved ongoing pregnancy or cumulative outcomes with freeze-all/FET approaches in adenomyosis populations—though we still lack large randomized trials to define exactly who benefits most.


“Ultra-long” GnRH agonist suppression: helpful for some, not all


A common uterine-prep approach is prolonged GnRH agonist downregulation (often 2–3 months) before embryo transfer—sometimes called an “ultra-long” protocol.


Recent evidence syntheses describe this as one of the more consistently supported medical strategies to improve implantation and reduce miscarriage risk, particularly when paired with frozen embryo transfer. At the same time, other analyses—especially those looking at fresh transfer cycles—show mixed results, and there is concern that longer suppression protocols can reduce oocyte yield for some patients. That matters because fewer eggs can mean fewer embryos, which can reduce cumulative live birth chances over multiple transfers.


A practical way to think about it is:

  • If your main issue is suspected uterine receptivity, suppression before FET may help.
  • If your main limitation is low ovarian reserve or a need to maximize embryo numbers quickly, aggressive suppression before egg retrieval may work against your goals—so some clinics prefer embryo banking first, then uterine suppression, then FET.


Other medical pre-treatments (progestins, dienogest, aromatase inhibitors)


Reviews describe several alternatives or add-ons:

  • Progestin-based options (like an LNG-IUS or oral dienogest) appear promising in some observational data for implantation/ongoing pregnancy, but are less extensively studied than GnRH agonists for IVF outcomes.
  • GnRH agonist + letrozole (an aromatase inhibitor) is sometimes proposed for severe or “refractory” cases or repeated failures, but supporting evidence is limited to smaller studies/series—best framed as a highly individualized, specialist-level approach rather than a universal standard.
  • Continuous combined oral contraceptives are often used for symptom control or scheduling but do not have strong adenomyosis-specific evidence for improving IVF outcomes.


Struggling with Adenomyosis and Fertility?

Our specialists are here to help you understand your condition and explore your treatment options.

Schedule Your Consultation

Fertility-sparing procedures: surgery and thermal ablation—what do outcomes look like?


If symptoms are severe (pain, bleeding) and adenomyosis is believed to be a major driver of infertility, some patients consider procedures aimed at reducing adenomyosis while keeping the uterus.


A 2025 systematic review and meta-analysis pooling non-randomized studies reported that after adenomyomectomy (surgical excision), about 4 in 10 patients had a delivery/live birth on average across studies (pooled delivery rate ~39.5%). After grouped image-guided thermal ablation techniques (such as HIFU/RFA/MWA), the pooled delivery rate was around 32.5%. These numbers are not head-to-head proof that one option is better—they reflect heterogeneous studies with different patient selection and follow-up.


Two additional details patients should know from this body of literature:

  1. Miscarriage/pregnancy loss is not negligible, and pooled estimates varied widely. In that meta-analysis, pregnancy loss appeared higher after thermal ablation than after adenomyomectomy, but the variation between studies was very large—meaning your individual risk could be quite different depending on age, lesion type, and how pregnancy was achieved (spontaneous vs IVF).
  2. Cesarean delivery was extremely common after adenomyomectomy in published cohorts (nearly universal in pooled data). This likely reflects both surgical scar considerations and clinician preference for planned cesarean in higher-risk uteruses. It doesn’t automatically mean you personally “must” have a C-section, but it is a strong signal that pregnancy after adenomyomectomy is often managed as higher risk.
  3. Uterine rupture, especially after an adenomyomectomy, is a very real risk and can occur well before fetal viability. So, for example, a pregnancy may be going well after all the early challenges are successfully navigated. But if a rupture occurs at 16 weeks, there is no way to save the baby and it may lead to uncontrolled hemorrhage on top of that. Similarly, a rupture around term can still result in a dangerous and life threatening hemorrhage. So, these are very real risks of consider.


Pregnancy after IVF or treatment: are there specific risks to watch for?


Most people with adenomyosis who conceive will not experience rare complications—but adenomyosis may identify a subgroup that benefits from more proactive monitoring.


Second-trimester loss signals: possible association with adenomyosis


A 2026 retrospective IVF study focusing on second-trimester pregnancy loss (a rare outcome) found that adenomyosis was more common among those who experienced second-trimester loss than among controls who had live births, among patients with uterine evaluation available. Most losses were linked to PPROM (water breaking early) and cervical insufficiency. This does not prove adenomyosis causes these losses, but it supports discussing whether you should have high-risk obstetric (MFM) involvement, cervical-length monitoring, or other surveillance—especially if you also have uterine scarring or other uterine factors.


Cesarean considerations: uterine torsion may be underrecognized in adenomyosis


A 2026 surgical cohort of patients with adenomyosis undergoing cesarean delivery reported asymptomatic uterine torsion discovered at surgery in a notable minority of cases (especially in focal-type adenomyosis within that cesarean cohort). Patients typically won’t feel this and routine ultrasound often won’t detect it, so the practical takeaway is not “watch for symptoms,” but rather: if you have known adenomyosis and may need a C-section, it can be worth ensuring your team is aware of the diagnosis and prepared for altered anatomy and non-standard incisions if needed.


Contraception note (for future planning): LNG-IUS and ectopic pregnancy


The levonorgestrel IUD (LNG-IUS) is widely used to treat adenomyosis symptoms. Pregnancy with an IUD in place is uncommon, but a 2025 case report highlights that if pregnancy occurs with an LNG-IUS—even if the device is correctly positioned—ectopic pregnancy is a critical rule-out. This is more of a safety reminder: if you have an IUD and a positive pregnancy test, urgent evaluation matters.


Practical takeaways and questions to consider


Use these questions to make appointments more productive and to ensure your plan matches your priorities:

  • “Based on my imaging, do I have focal or diffuse adenomyosis, and what does my junctional zone look like?”
  • “Is my plan aiming for fresh transfer or freeze-all with FET—and why is that the best fit for my adenomyosis pattern?”
  • “Would you recommend 2–3 months of GnRH agonist suppression before transfer? If yes, do we do it before retrieval or after embryos are banked?”
  • “How does my AMH/AFC (ovarian reserve) change the pros/cons of prolonged suppression?”
  • “If we consider fertility-sparing procedures, am I a candidate for adenomyomectomy or HIFU/RFA? What are the expected symptom benefits, fertility expectations, and pregnancy risks?”
  • “If I conceive, should I have early referral to maternal-fetal medicine or additional monitoring (for example, cervical-length checks), given my history and uterine findings?”


What we still don’t know


We still lack enough randomized controlled trials comparing key strategies (fresh vs freeze-all, different suppression regimens, medical vs surgical approaches) specifically in well-characterized adenomyosis subtypes. Many published results come from retrospective cohorts where patients differ in age, ovarian reserve, endometriosis coexistence, infertility duration, and prior treatments—factors that can strongly influence outcomes.


We also don’t yet have a universally accepted way to translate imaging findings into a personalized fertility forecast. Newer tools (including ultrasound feature sets and prediction models) are improving how clinicians describe disease, but current models show only modest predictive ability before treatment—meaning uncertainty is real, and many people will only learn what works through a stepwise plan.


Bottom line: Adenomyosis can affect fertility and pregnancy, but it doesn’t remove your options. The most helpful next step is usually not a one-size-fits-all protocol—it’s clarifying your adenomyosis subtype and your fertility priorities (time, symptoms, ovarian reserve), then choosing a plan that protects both embryo potential and uterine receptivity and considers all risks.

References

  1. Satwik, Verma, Thakur. Strategies to Improve Assisted Reproductive Technique Outcomes in Women with Adenomyosis: A Narrative Review. Journal of Human Reproductive Sciences. 2025. PMID: 40740622 PMCID: PMC12306718

  2. Liu, Wang, Li et al.. Reproductive outcomes after fertility-sparing interventions for symptomatic adenomyosis: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 2025. PMID: 41206447 PMCID: PMC12595728

  3. Martire, Costantini, Zupi et al.. Ectopic Pregnancy with a Normally Located Levonorgestrel-Releasing Intrauterine System in a Woman with Adenomyosis: Case Report and Literature Review. Journal of Clinical Medicine. 2025. PMID: 41517521 PMCID: PMC12786598

  4. Alson, Björnsson, Henic et al.. Machine learning prediction of live birth after IVF using the morphological uterus sonographic assessment group features of adenomyosis. Scientific Reports. 2026. PMID: 41620505 PMCID: PMC12865173

  5. Rubin, Nussbaum, Noruzi et al.. Second-trimester pregnancy loss after in vitro fertilization: risk factors and risk reduction. F&S Reports. 2026. PMID: 41694253 PMCID: PMC12905596

  6. Etrusco, Maiorana, Roncarati et al.. Effect of extended hormonal suppression in patients with adenomyosis undergoing embryo transfer. Frontiers in Reproductive Health. 2026. PMID: 41727871 PMCID: PMC12916556

  7. Yoshida, Iriyama, Ariyoshi et al.. An Unrecognized High Incidence of Asymptomatic Uterine Torsion in Pregnancies with Adenomyosis that Complicate Cesarean Delivery. Reproductive Sciences. 2026. PMID: 41507567 PMCID: PMC12948917

  8. Zhou, He, Xu et al.. Single-cell transcriptomic landscape of the mid-secretory eutopic endometrium reveals receptivity defects in adenomyosis. Journal of Translational Medicine. 2026. PMID: 41787497 PMCID: PMC12964726

Quick Answers

When is hysterectomy recommended for adenomyosis?

A hysterectomy is typically considered for adenomyosis when symptoms are severe and clearly uterus-driven—most often heavy bleeding (sometimes with anemia), intense cramping, pelvic pressure, and daily quality-of-life disruption—and you’re not planning future pregnancy. It’s the most definitive option because adenomyosis lives within the uterine muscle, so removing the uterus removes the source of the problem.


In practice, we usually weigh hysterectomy most strongly when conservative options haven’t brought acceptable relief, aren’t tolerated, or don’t fit your goals. The decision also depends on the pattern and extent of disease (diffuse adenomyosis versus a more focal adenomyoma that may be removable while preserving the uterus) and whether endometriosis may also be present. If endometriosis is part of the picture, it’s important to know that hysterectomy alone doesn’t treat disease outside the uterus—durable symptom relief depends on addressing all pain generators.


If you’re wondering whether you’re at the point where hysterectomy makes sense, our team can help clarify what’s most likely driving your symptoms, review imaging, and walk you through uterus-preserving versus definitive surgical paths so you can choose the option that best matches your relief and fertility priorities.

Read full answer

Which adenomyosis symptoms most affect daily life?

Adenomyosis symptoms that most disrupt quality of life usually come from two main issues: how the uterus bleeds and how it hurts. Many patients describe heavy or prolonged periods that interfere with work, school, travel, and sleep—sometimes with flooding, frequent pad/tampon changes, and fatigue that can follow significant blood loss. Severe period pain (often more than “normal cramps”) is also common, and it can feel deep, aching, or pressure-like, sometimes accompanied by an enlarged, tender uterus and a sense of pelvic heaviness or bloating.


Outside of the period itself, adenomyosis can contribute to chronic pelvic pain, pain with sex for some people, and bowel or bladder discomfort—especially when symptoms flare around the menstrual cycle. It can also overlap with endometriosis, and when both are present symptoms may intensify or become harder to tease apart. If your day-to-day life is being shaped by bleeding, pain, pressure, or fertility stress, our team can help you sort out whether adenomyosis, endometriosis, fibroids, or more than one condition may be driving the pattern—and what next-step options make sense for your goals.

Read full answer

Can endometriosis cause infertility and pelvic pain in your 20s?

Yes. Endometriosis can absolutely show up in your late 20s and it can be a driver of both chronic pelvic pain and fertility challenges. Pain can include severe or worsening period cramps, pain with sex, bowel or bladder pain, and “flare” patterns that track with your cycle—although symptom severity doesn’t always match how much disease is present.


Endometriosis can affect fertility in several ways, including adhesions that distort tubo‑ovarian anatomy, inflammation and immune signaling that interferes with fertilization or embryo development, and ovarian factors—especially when endometriomas are involved. For some patients, the uterine environment also matters, particularly when adenomyosis is present alongside endometriosis. In our practice, we focus on listening to your full symptom and fertility story and then building an evaluation that looks for endometriosis while also checking for common look‑alikes or coexisting issues, so we can tailor a plan to your goals—whether that’s pain relief, preserving fertility, or both.

Read full answer

Why do I have chronic fatigue and pelvic pain?

Chronic fatigue plus pelvic pain often feels “unexplainable” because it’s rarely caused by just one issue—and many of the most common drivers don’t show up on routine labs or a quick ultrasound. Endometriosis and adenomyosis can cause persistent pelvic pain, painful periods, bowel/bladder symptoms, and deep fatigue through inflammation, disrupted sleep, heavy bleeding (and possible iron deficiency), and the sheer energy cost of living with ongoing pain. It’s also common for more than one gynecologic condition to coexist—like fibroids, polyps, or benign cysts—so a single label may not fully match what you’re experiencing.


Another reason symptoms can persist is that the nervous system can become more pain-sensitive over time (often called central sensitization), meaning pain can spread, linger outside your cycle, or feel disproportionate to what imaging shows. In those cases, symptom relief alone can miss the bigger picture: we think in terms of both treating disease (for example, addressing endometriosis lesions or uterine drivers like adenomyosis/fibroids) and building a personalized pain-management plan so your body can “turn down the volume” on pain signals.


If your fatigue and pelvic pain have been brushed off or left without a clear plan, our team can help you sort through the likely contributors, including endometriosis/adenomyosis and common coexisting conditions, and map next steps that fit your goals. You can explore our educational resources on fatigue, chronic pelvic pain, and comprehensive treatment approaches, and reach out to schedule a consultation when you’re ready.

Read full answer

Why does sex hurt more around my period?

Pain with sex that flares around your period often points to a hormonally driven pelvic pain source—meaning tissue and nerves in the pelvis become more inflamed and reactive in the days leading up to bleeding and during menstruation. Endometriosis is a common reason: lesions can irritate nearby nerves and organs, and the inflammatory chemicals they produce can amplify pain signals. Adenomyosis (endometrial-like tissue within the uterine muscle) can also make the uterus unusually tender and crampy, so penetration, orgasm-related uterine contractions, or even pelvic pressure can feel painful around that time.


The “where” and “when” of the pain matters. Deep pain with penetration can be related to endometriosis near the uterosacral ligaments, cervix/vaginal fornix, rectovaginal space, bowel, or bladder—especially if scarring or adhesions have altered how those structures move. Pain after sex or after orgasm can happen when pelvic floor muscles spasm or when uterine contractions tug on sensitized areas. If this pattern is recurring, our team can help map your symptom timing and triggers and evaluate for endometriosis, adenomyosis, pelvic floor dysfunction, and overlapping bladder/bowel involvement so treatment targets the real driver of your pain rather than just masking it.

Read full answer

Reach Out

Have a question?

Lotus Endometriosis Institute provides California-based surgical evaluation and advanced excision care for patients with suspected endometriosis, adenomyosis, complex pelvic pain, and related conditions.


Many patients contact us from outside California to learn whether traveling for in-person evaluation and possible surgery may be appropriate.

Call Us

(424) 255-1340

(805) 920-0909

Fax: (805) 935-4338

Santa Monica, CA

2121 Santa Monica Blvd, Santa Monica, CA 90404

Operating Hours

8am - 5pm
Monday - Friday

Arroyo Grande, CA

154 Traffic Way, Arroyo Grande, CA 93420